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Fortication of cereal ours may be a useful public
health strategy to combat iron deciency. Cereal
ours that are used shortly after production (e.g.,
baking our) can be fortied with soluble iron com-
pounds, such as ferrous sulfate, whereas the ma-
jority of ours stored for longer periods is usually
fortied with elemental iron powders to avoid un-
acceptable sensory changes. Elemental iron pow-
ders are less well absorbed than soluble iron com-
pounds and they vary widely in their absorption
depending on manufacturing method and physico-
chemical characteristics. Costs vary with powder
type, but elemental iron powders are generally less
expensive than ferrous sulfate. This review evalu-
ates the usefulness of the different elemental iron
powders based on results from in vitro studies, rat
assays, human bioavailability studies, and efcacy
studies monitoring iron status in human subjects. It
concludes that, at the present time, only electrolytic
iron powder can be recommended as an iron forti-
cant. Because it is only approximately half as well
absorbed as ferrous sulfate, it should be added to
provide double the amount of iron.
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Introduction
Iron de ciency is a major public health problem in
developing countries that affects up to 50% of infants,
children, and women of childbearing age in poorer pop-
ulations of Africa, Asia, and Latin America. Approxi-
mately one-half of these people suffers from the most
severe form of iron de ciency, iron de ciency anemia
(IDA). IDA is an important cause of cognitive de cits in
infants and young children;1 it can cause premature
birth2 and increased maternal3 and perinatal mortality.4
IDA also has a profound effect on work performance and
productivity.5,6 It has important negative economic con-
sequences in countries where it is a major health prob-
lem.7 For health and economic reasons, therefore, many
developing countries are evaluating strategies to combat
iron de ciency. Whereas food forti cation is usually
considered the most cost-effective long-term approach to
combat nutrient de ciencies,8 it should form part of a
multiple-strategy approach that includes iron supplemen-
tation and dietary modi cation. Forti cation of wheat
 our with iron and vitamins has been used in the United
States and some European countries for more than 50
years. Although wheat  our forti cation was suggested
as the main reason for the improved iron status of
Swedish women,9 its ef cacy has never been properly
evaluated10 and its usefulness has been questioned. To
understand the issues that underlie the current debate, it
is helpful to consider the factors that in uence the bio-
availability of forti cation iron.
Factors Affecting the Bioavailability of
Fortication Iron
The amount of forti cation iron absorbed from a partic-
ular diet depends on three factors. These include the
composition of the diet, the iron status of individuals
consuming the diet, and the relative bioavailabilityof the
iron forti cant.11 There are two types of iron in the diet,
heme iron (derived from hemoglobin and myoglobin)
and nonheme iron (derived mainly from cereals, vegeta-
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bles, and fruit). Most forms of nonheme iron in a meal,
whatever the origin, enter a common pool during diges-
tion and are thus equally susceptible to a number of
promoters and inhibitors of iron absorption.12 The major
promoters of iron absorption are meat and ascorbic
acid,12 whereas the major inhibitors are phytates and
polyphenols.13
Soluble iron forti cants, such as ferrous sulfate,
enter the common pool of nonheme iron completely and
are absorbed to the same degree as is intrinsic nonheme
iron in the diet. This iron is well absorbed when the
diet contains adequate amounts of ascorbic acid and/or
meat, but it is poorly absorbed from diets in which
inhibitors of iron absorption predominate.14 Ferrous
sulfate and other soluble iron complexes can only be
used when the forti ed cereal is consumed shortly
after production; this is because they are chemically
reactive and tend to produce undesirable organoleptic
changes with time in the vehicles to which they are
added.10,15,16
When cereal products will be stored for longer
periods, forti cants that are less soluble in the upper
gastrointestinal tract are frequently used. Although such
inert compounds do not cause organoleptic changes
when stored in a variety of vehicles, they tend to be less
well absorbed because they are less soluble in gastric
juice. Once dissolved, their absorption, like all iron
present in the common pool, is dependent on the enhanc-
ers and inhibitors of iron absorption present in the meal
and on the iron status of the consumer. The most widely
used of these compounds, particularly in cereal products,
is elemental iron. Elemental iron is relatively inexpen-
sive and does not cause adverse  avor and color changes
that often occur with prolonged storage of soluble iron
compounds. Wheat and maize  ours are selected as
forti cation vehicles because these foods are usually
centrally processed and regularly consumed in suf cient
quantities by at-risk population groups. There are, how-
ever, certain unanswered questions relating to the use of
elemental iron because it is not a single entity but rather
exists in various forms depending on the manufacturing
process.
Three distinct families of elemental iron powders
have been used: iron reduced by hydrogen or carbon
monoxide, electrolytic iron, and carbonyl iron. Each
manufacturing process produces a powder with a distinct
particle size distribution, density, surface area, chemis-
try, and shape, all of which can affect iron bioavailabil-
ity. The unique qualities of the various powders have
largely been overlooked owing to the food industry’s
frequent use of the generic name “reduced iron.” It is
therefore not possible to give a single recommendation
regarding the use of elemental iron powers in cereal
forti cation.
Current Use of Iron Forticants
In 1941, the United States was the  rst country to enrich
low-extraction wheat  our with iron and vitamins; by
1965, virtually all white wheat  our and wheat bread
and most corn meal (86–94%), grits, and macaroni
products were forti ed with iron, as were a large pro-
portion of other cereal products.17 By 1979, most of
the ready-to-eat breakfast cereals (92%) were also forti-
 ed with iron (together with a selection of vitamins)
to provide some 25% of the Recommended Daily Al-
lowances per serving.18 And as commercial cereal–
based weaning foods became popular, they were forti ed
with iron because infants are highly susceptible to iron
de ciency.19,20
Mandatory enrichment of white wheat  our with
iron was introduced in the United Kingdom and Canada
in 1953 and many other countries have since introduced
either mandatory or voluntary enrichment, usually add-
ing suf cient iron to white wheat  our to restore the level
to that in whole grain or 80%-extraction  our (U.K.).
Countries that require iron to be added to wheat  our
include Chile (30 ppm), Guyana, Kenya, and Zambia (all
29–36 ppm), Nigeria (35 ppm), United Kingdom (16.5
ppm), United States (44 ppm),21 Mexico (24 ppm),
and various Central American countries including
El Salvador, Costa Rica, Guatemala, Honduras, Nica-
ragua, and Panama. In Germany, Holland, Belgium,
Spain, and Switzerland, iron forti cation of wheat  our
is voluntary.
Because of its high nutritional bioavailability and
low cost,  ne dried ferrous sulfate is often the best iron
source for forti cation. It can be used in bakery  our
(which is typically used within a month after milling),
in semolina, and in other types of low-moisture
wheat products such as noodles, macaroni, and spaghetti.
More widespread use of ferrous sulfate is limited by
the fact that it often causes rancidity in stored cereal
 ours and unwanted color changes in some cereal
products.16,22 An alternative to ferrous sulfate is fer-
rous fumarate, which, although more expensive and
insoluble in water, has a bioavailabilitysimilar to ferrous
sulfate. It therefore causes fewer organoleptic problems
and some European manufacturers use it to fortify infant
cereals.10
Elemental iron powders are, by far, the most widely
used forti cants for wheat  our and other cereal prod-
ucts, including breakfast and infant cereals.23,24Whereas
elemental iron powders are the most widely used iron
forti cants, many researchers have investigated whether
they are suf ciently well absorbed from cereal products
to be nutritionally useful.24–28 In several early human
absorption studies, discrepant results were obtained,with
bioavailability ranging from very low to  gures equiva-
lent to those obtained with ferrous sulfate.19,25–31 These
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differences can be ascribed to the fact that the labeled
experimental powders were not produced in the same
ways as commercial iron powders and, therefore, had
different physico-chemical characteristics. Attempts to
characterize the different iron forti cation compounds
according to their physicochemical characteristics, solu-
bility in dilute acid, and ability to replete hemoglobin in
iron-de cient rats32,33 revealed many differences. Inter-
pretation of the various  ndings is complicated by failure
to fully characterize the iron powders that were being
tested. It was still possible to reach certain general
conclusions: powders with smaller particle size, larger
surface area, and greater solubility in dilute acid tended
to be better absorbed.
From these  ndings it is clear that there is no generally
accepted view whether or not elemental iron should be
recommended for food forti cation. To answer this ques-
tion, SUSTAIN organized a workshop in Monterrey, Mex-
ico, in September 2000, that brought together specialists in
iron nutrition and iron forti cation and representatives from
companies that manufacture and distribute elemental iron
powders. Published evidence was reviewed and a consen-
sus, which summarized the current knowledge and made
recommendations for the future, was prepared. The current
report contains the literature review, together with the
conclusions and recommendations from the SUSTAIN
workshop. The following sections describe the characteris-
tics of elemental iron powders used in food forti cation and
their bioavailabilityas measured by in vitro methods, by rat
hemoglobin repletion studies, by human bioavailability
studies, using radioactive or stable isotopes, and by moni-
toring iron status.
Elemental Iron Powders Used in Food
Fortication
Historically, three distinct families of elemental iron pow-
ders have been used in food forti cation.34 These are
hydrogen-reducedand carbon monoxide–reduced “sponge”
iron, electrolytic iron, and carbonyl iron. More recently,
reduced iron powder manufactured by Quebec Metal Pow-
ders (QMP) has been added to the list of iron powders
available for food forti cation. The QMP reduced iron
powder has been referred to as “atomized” iron.35Owing to
their different manufacturing methods, there are major dif-
ferences in the chemical and physical properties of these
families and their absorbability from foods. There are also
considerable differences within individual powder types
owing to the different grinding and sieving procedures used
because of different particle size distributions.All commer-
cial elemental iron powders for food forti cation contain
96% iron. The powder characteristics that in uence ab-
sorption are those that in uence its dissolution in the gastric
juice. These include the microstructure of the particle
(which depends on the method of manufacture), other metal
impurities, particle size, shape, and surface area.
Hydrogen- and CO-reduced sponge iron powders
are made at an elevated temperature by using hydrogen
or carbon monoxide to reduce iron oxide to its elemental
state.34Two types of iron oxide are used to produce these
reduced iron powders commonly referred to as “sponge”
iron powders. The  rst is mill scale, a by-product of the
steel industry; the second is natural iron ore. Mill scale
mainly consists of Fe3O4 (magnetite) and is usually
reduced by hydrogen, whereas iron ore consists of Fe2O3
(hematite) and is usually reduced by carbon monoxide.
These compounds have the lowest purity of the food-
grade iron powders ( 96% Fe) and may contain ele-
ments such as C, Mg, Al, Si, P, S, Cr, Mn, Ni, and Cu,
many of which are present as acid insoluble oxides and
therefore would be expected to reduce solubility. The
iron powders are ground by a variety of different milling
techniques. Milling is usually carried out under an inert
atmosphere to limit surface oxidation, the greatest source
of impurity of any iron powder. The particle shape is
considered sponge-like, irregular, and porous. QMP re-
duced iron powders are made by a different process.
Details of the QMP process and other methods used to
produce iron powders used in food enrichment can be
found in the Handbook of Powder Metal Technologies
and Applications.36
Electrolytic iron is produced in brittle sheets of
elemental iron that are then ground into powders. The
thin sheets are made by electrolytic migration of iron
from a pure iron anode through a ferrous sulfate solution
onto a stainless steel cathode. Electrolytic iron powders
contain signi cantly fewer impurities than reduced iron
powders ( 99% Fe), a quality that makes them ductile.
The particle shape is described as highly irregular and
fern-like with a high surface area. This material can
easily be ground to a  ne particle size, which, together
with a large surface area and high purity, is an important
factor in improving the solubility of elemental iron
powders in gastric juice.
Carbonyl iron powders are manufactured directly
from reduced elemental iron or from scrap iron. The
metal reacts with carbon monoxide under heat and pres-
sure to produce iron pentacarbonyl, which is then de-
composed under controlled conditions yielding carbonyl
iron powder and carbon monoxide gas. A second reduc-
tion treatment with hydrogen is necessary to remove the
carbon impurities to produce powders containing 98%
iron, the major impurities being carbon and nitrogen. The
carbonyl iron particles are dense spheres of extremely
small particle size (2–10 m) whose structure is charac-
terized by concentric shells of iron arranged in an onion-
like fashion. The particles have a smooth, dense outer
layer, which exposes them to less surface oxidation than
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reduced iron powders or electrolytic iron powders. A
mixture of ferrous oxides and ferric oxides form on the
surface of iron powders. Some oxidation is considered
nutritionally bene cial because ferrous oxide is very
soluble in gastric acid and the oxidized areas provide
attack sites for particle dissolution.34
The milling and sieving procedures used determine
the particle size of reduced and electrolytic iron powders.
A powder generally consists of discrete particles of dry
material with a maximum dimension of 1 mm. Food
Chemicals Codex (FCC) speci cations37 require that
reduced iron powders used to fortify foods are passed
through a 100-mesh sieve (particle size 149 m) and
that electrolytic and carbonyl iron powders are passed
through a 325-mesh sieve (particle size 44 m). Man-
ufacturers also provide reduced iron powders that have
been passed through a 325-mesh sieve. They form a large
proportion of powders sold although this standard is not
stipulated in the FCC. Whereas it would seem that
particle size alone is insuf cient to ensure enough iron is
absorbed to be nutritionally useful, other factors such as
surface area, porosity, or purity have not been suf -
ciently investigated to enable the formulation of clear
guidelines. Only a few companies manufacture the vast
majority of elemental iron powders used in food forti -
cation today. Each company manufactures one type of
powder using one manufacturing process. Reduced iron
powders are manufactured by Ho¨gana¨s AB, Sweden
(CO-reduced); North American Ho¨gana¨s (formerly Py-
ron Corporation), United States (H-reduced); and Que-
bec Metal Powders (QMP), Canada (reduced). Electro-
lytic iron powder is manufactured by OMG Americas,
which is in the United States (formerly Glidden, A131),
and International Metal Powders (IMP) India. BASF,
Germany, and International Speciality Products (ISP),
United States, manufacture carbonyl iron. The two new-
est companies to enter the market for food-grade iron
powders are QMP and IMP. QMP started approximately
20 years ago and IMP began producing electrolytic iron
in the early 1970s. Manufacturing companies sell the
iron powders to the food ingredient suppliers and pre-
mix manufacturers who in turn supply the food industry.
The characteristics of the different iron powders avail-
able on the market today are given in Table 1.
Hydrogen-reduced iron and electrolytic iron are pro-
vided as well-characterized single powders that should
differ only slightly from batch to batch. Carbon monox-
ide–reduced iron powders can have variable composition
depending on the market requirement. Three major par-
ticle sizes of CO-reduced iron are commercially avail-
able, including the large particle size 100-mesh, 300-
mesh for Europe, and 325-mesh for the United States.
Carbonyl iron (BASF) is offered as 99.5% iron or
98% iron, but both products have the same particle size
distribution with all particles being 21 m. Food com-
panies in the United States and Europe mainly use the
small particle size powders (i.e., 50 m or 45 m).
The large particle size CO-reduced iron ( 150 m) is
the least expensive product and is commonly used in
many developing countries. These reduced iron powders
are mainly used to fortify cereal  ours and breakfast
cereals. Electrolytic iron is mainly used to fortify infant
cereals, particularly in the United States; however, it is
also sometimes recommended for cereal  our forti ca-
tion and is the speci ed iron compound in the micronu-
trient formula for wheat  our forti cation in six coun-
tries in Central Asia. Carbonyl iron is only occasionally
used to fortify foods because of its greater cost.
Bioavailability of Elemental Iron Powders
In Vitro Methods
Different in vitro methods have been used to estimate the
bioavailability of elemental iron powders; there have
Table 1. Iron Powders Available for Food Fortication in the Year 2000
Powder Type Manufacturer Particle Size*
H-reduced (sponge) North American Ho¨gana¨s, USA 325 mesh
Reduced QMP, Canada 325 mesh
CO-reduced (sponge) Ho¨gana¨s AB, Sweden 325 mesh
300 mesh
100 mesh
Electrolytic OMG Americas, USA (Glidden A131) 325 mesh
(39% 10 m, 35% 10–20 m, 16% 20–30 m,
8% 30–44 m)
Electrolytic IMP, India 325 mesh
Carbonyl BASF, Germany 325 mesh ( 99.5% Fe or 90% Fe)
(10% 3.5 m, 50% 8.5 m, 100% 21 m)
Carbonyl ISP, USA 325 mesh (mean particle size 5 m)
*325 mesh means that ca. 95% of particles are 45 m; 300 mesh means that ca. 95% of particles are 50 m; 100 mesh means
that ca. 95% of the particles are 150 m.
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been few studies, however, comparing in vitro results
directly with rat hemoglobin repletion data or human
absorption data. Results from in vitro studies therefore
do not provide information that can be used to predict
bioavailability of the different powders. In the future,
however, these methods may provide a simple approach
that could be used to optimize and characterize iron
powders for food forti cation.
Several authors have evaluated solubility in dilute
HCl, although the early studies of Pla and Fritz38 found
poor agreement between the solubility of a range of iron
compounds in dilute HCl (pH 1.1) and their relative
bioavailability in rat hemoglobin repletion studies. Shah
et al.33 proposed that the suitability of elemental iron
powders for food forti cation should be judged by their
solubility in dilute HCl. To measure solubility, investi-
gators recommended that 100 mg powder be shaken with
250 mL of 0.2% HCl (pH 1.2) at 37°C, and that only
powders that are 90% soluble after 3 hours should be
used for food forti cation. Motzok et al.,39 using a
similar method, showed that the solubility of elemental
iron powders after 10 minutes in dilute acid agreed with
relative bioavailability values (RBV) from rat studies.
They reported 44% solubility of electrolytic iron, 45%
and 31% with two different batches of carbonyl iron, 8%
for CO-reduced iron, and 8% each for two different
batches of H-reduced iron. Using the method of Shah et
al.,33 Forbes et al.40 reported that electrolytic iron was
75% dissolved in dilute HCl after 30 minutes and that the
relative human absorption of electrolytic iron compared
with ferrous sulfate was also 75%. The other compound
tested in this study was ferric orthophosphate,which was
only 3 to 4% soluble in dilute acid after 30 minutes but
was 25% as well absorbed as ferrous sulfate in man.
Earlier, Bjo¨rn-Rasmussen et al.31 reported a positive
correlation between the solubility of four experimental
reduced iron compounds in dilute HCl and their absorp-
tion in human subjects.
Forbes et al.40 also reported good agreement of iron
absorption in man from electrolytic iron and ferric or-
thophosphate with in vitro dialyzable iron from those
compounds as measured after a simulated gastric and
intestinal enzymatic digestion. The same technique was
also recommended by Whittaker et al.41 as a useful
method to predict the bioavailability of forti cation iron
in man, but a careful evaluation of different elemental
iron powders using this method still remains to be made.
Rat Studies
In 1989, Forbes et al.40 reported that the Association of
Of cial Analytical Chemists (AOAC) hemoglobin reple-
tion test in rats42 was a good predictor of the RBV of an
iron forti cation compound in humans. In this assay,
weaning rats are  rst rendered iron de cient and anemic
by feeding a low-iron diet for 4 weeks; the rats are then
repleted over 2 weeks with the test iron compounds.
RBV of the iron compound is obtained by comparing the
increase in hemoglobin of the test iron compound with
the increase in hemoglobin with ferrous sulfate. Many
hemoglobin repletion assays using the AOAC method
were made on commercial iron powders used in the
1970s and 1980s for cereal forti cation mainly in the
United States. Results from the assays are now presented
and reviewed.
Electrolytic iron. Studies with electrolytic iron (Ta-
ble 2) have reported RBV values from 16 to 70, with a
mean of 44, in commercial powders conforming to the
FCC speci cations37 that were passed through a 325-
mesh sieve. The commercial powder Glidden A131 was
tested independently  ve times between 1975 and 1989,
yielding RBV values from 42 to 59, with a mean of 48.
This electrolytic iron powder is still widely used to
fortify infant cereals.50 Most, but not all, of the electro-
lytic iron powders had an RBV value of 40.
H-reduced iron. H-reduced iron powders (Table 3)
reportedly have lower RBV values than electrolytic iron
Table 2. Studies Using Relative Bioavailability (RBV) in Rats to Evaluate Electrolytic Iron
Authors Description of Powders RBV
Ranhotra et al.43 Commercial 39
Pla et al.44 Commercial 1 325 mesh 50
Commercial 2 325 mesh 45
Pennell et al.45 Glidden A131 325 mesh 47
Coccodrilli et al.46 Commercial 98% 40 m 70
Shah et al.33 Commercial 1 99% 40 m 32
Commercial 2 99% 40 m 37
Commercial 3 99% 40 m 16
Sacks & Houchin47 Glidden A131 48
Motzok et al.39 Glidden 99% 40 m 42
Shah & Belonje48 Commercial sample for cereals 41–44
Romanik & Miller49 Glidden A131 59
Hurrell et al.22 Glidden A131 44
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powders. Coarse powders that conform to FCC speci -
cations37 by passing through a 100-mesh sieve (149 m)
have yielded RBV values of approximately 20.32,47 The
reported RBV values for other commercial powders have
varied from 13 to 54, with a mean of 30. Commercial
powders, most of which pass through a 325-mesh sieve,
have also occasionally given low RBV values, i.e., 1339
and 25.46 The most recent commercial powder, tested in
1989, however, gave an RBV of 54.22
CO-reduced iron. Only three studies have reported
data on commercial CO-reduced iron powders (Table 4),
yielding RBV values from 12 to 32 (mean 19); this
indicates these powders have generally low bioavaila-
bility.
Carbonyl iron. All carbonyl iron powders pass
through a 325-mesh sieve. Reported RBV values are
between 27 and 66 (mean 47), and clearly depend on the
mean particle size (Table 4). Powders in which 90% of
the particles are 5 m have yielded a mean RBV value
of 56, whereas the largest particle size commercial pow-
der, in which 80% of the particles were 20 m, had
an RBV of 39.
Particle size versus method of manufacture.
Whereas it is clear that particle size reduction increases
the RBV of all iron powders, elemental iron powders of
identical particle size manufactured by different methods
have yielded different RBV values. Thus the RBV values
for electrolytic iron powders of a speci ed particle size
are higher than those for H-reduced iron of the same
particle size, which is, in turn, higher than those for
CO-reduced iron.54 (Table 5) Whereas direct compari-
sons between carbonyl iron powder and electrolytic pow-
Table 4. Studies Using Relative Bioavailability (RBV) in Rats to Evaluate Carbonyl and CO-Reduced Iron
Authors Description of Powders RBV
Carbonyl iron Pla et al.44 95% 5 m 47
Shah et al.33 mean particle size 4 m 61
mean particle size 3 m 51
Motzok et al.39 86% 10 m 31
93% 10 m 27
Sacks & Houchin47 90% 5 m 66
90% 8 m 63
80% 20 m 39
Hurrell et al.22 BASF 52
Kosonen & Mutanen53 Lohmann 35
CO-reduced iron Coccodrilli et al.46 88% 40 m 32
Shah et al.33 84% 40 m 12
Motzok et al.39 Mallinkrodt 60% 40 m 12
Table 3. Studies Using Relative Bioavailability (RBV) in Rats to Evaluate H-Reduced Iron
Authors Description of Powders RBV
Ranhotra et al.43 Commercial 37
Ranhotra et al.51 Commercial 325 mesh 42–48
Pla et al.44 Commercial 325 mesh 32
Commercial 100 mesh 18
Fritz et al.32 Commercial 27
Coccodrilli et al.46 Commercial 97% 40 m 25
Shah et al.33 Commercial 92% 40 m 18
Commercial 88% 40 m 24
Motzok et al.39 Glidden 92% 40 m 14
Pyron 99% 40 m 13
Sacks & Houchin47 Mallinkrodt no 4350 (mean particle
size 7 m)
Mallinkrodt no 4353 5% 10 m 27
25% 20 m 32
Glidden B 131 3% 10 m 35
Mallinkrodt—100 mesh 22% 20 m 24
Ranhotra et al.52 Commercial 49
Shah & Belonje48 Mallinkrodt—325 mesh 96% 44 m 28
Hurrell et al.22 Commercial—Riedel, Germany 54
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ders of identical particle size have not been made, car-
bonyl iron powders have yielded similar RBV values to
electrolytic iron of the smallest particle size (0 –10 m or
7–10 m) in rat hemoglobin repletion studies. (Table 5)
Effect of processing. Animal studies indicate that
neither bread baking nor infant cereal processing (wet
mixing and drying) in uence RBV. Pennell et al.45
reported that the RBV of an electrolytic iron powder was
47 when added directly to the rat diet, 49 when added to
the rat diet with the unforti ed rice infant cereal, and 45
when added to the diet after being processed with the rice
cereal. Similarly, Shah & Belonge48 reported that the
RBV of a reduced iron powder was 26, 28, and 30,
respectively, when added to the rat diet directly, when
added as part of iron forti ed  our, and when baked into
bread.
Extrapolation from rats to humans. The rat studies
using the AOAC hemoglobin repletion test would there-
fore predict that the relative bioavailability to humans of
the different commercial elemental iron powders, at least
those marketed in the 1970s and 1980s, is variable and
depends both on particle size and method of production.
Electrolytic and carbonyl iron powders that pass through
a 325-mesh sieve had the highest reported RBV values in
rats and would be predicted to be approximately half as
well absorbed in humans as ferrous sulfate. The rat
studies indicate that reduced iron powders are less well
absorbed than carbonyl or electrolytic iron powders and
have a more variable absorption. The coarse H-reduced
powders, which pass only through a 100-mesh sieve, like
the commercial CO-reduced powders, are predicted to be
approximately 20% as well absorbed as ferrous sulfate.
The  ner H-reduced powders, which pass through a
325-mesh sieve, are predicted to be 20 to 50% as well
absorbed as ferrous sulfate.
It is unclear how the elemental iron powders mar-
keted today (Table 1) compare with those studied in rats
20 to 30 years ago. The manufacturing process for
electrolytic iron would appear to have remained essen-
tially unchanged although there is no documented evi-
dence that the current electrolytic iron powders are iden-
tical to Glidden A-131. The manufacture of H-reduced
and CO-reduced sponge iron powders and carbonyl pow-
ders may have changed to some extent although the basic
processes are still the same. There are no clearly recog-
nizable rat studies testing the bioavailabilityof the newer
iron powders, such as the QMP reduced iron or the IMP
electrolytic iron, which have been introduced within the
last 30 years.
Human Bioavailability Studies
Seven human studies have been carried out to measure
the bioavailability of elemental iron powders added to
bread or infant cereal. (Table 6) In most studies, bio-
availability of the iron powder was compared directly
with that of ferrous sulfate added to the cereal product in
an identical manner. Two studies compared the absorp-
tion of the iron powder with that of the common pool
iron using an extrinsic radio-iron tag. The latter value
should approximate the absorption of ferrous sulfate
provided that the iron concentration of the pool iron is
similar to that of the forti cation iron. Six studies were
made with experimental iron powders labeled with radio-
iron or stable iron isotopes. Although these experimental
powders were sometimes very different from commer-
cial powders, in most cases they were suf ciently well
characterized so as to provide useful information. The
remaining study by Hallberg et al.28 is the only study that
has measured the absorption of a commercial iron pow-
der (carbonyl iron) irradiated to produce labeled mate-
rial. The amount of iron added per meal varied in the
seven studies from 1 to 5 mg. In general, as the amount
of iron added per meal increased, fractional absorption
decreased, but the absolute amount of iron absorbed
increased.55 Studies done prior to 1969 have not been
considered because of dif culties in de ning the charac-
teristics of the iron powders tested.
Hydrogen-reduced Iron
Iron absorption by human subjects from H-reduced iron
powders added to bread or infant cereal has been mea-
sured four times. (Table 6) A further study was done with
reduced iron55 but the method of production was not
stated. The isotopically labeled iron powders tested were
sometimes very different from the iron powders mar-
keted today. In the one infant cereal study,19 absorption
by infants from a small particle size powder (5–10 m)
was 4% and equivalent to the absorption of ferrous
sulfate. The relatively low absorption can be explained
by the high iron dose (5 mg/10 g cereal meal) and by the
Table 5. Inuence of Particle Size on
Bioavailability of Elemental Iron Powders
Production Method Particle Size ( m) RBV
Electrolytic 1 7–10 64
27–40 38
Electrolytic 2 0–10 76
10–20 75
20–40 48
40 45
H reduction 10–20 54
40 34
CO reduction 6–10 36
14–19 21
27–40 13
Carbonyl 4 69
4–8 64
Adapted from Fritz.5 4
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Table 6. Human Studies Measuring the Absorption of Elemental Iron Powders from Bread
and Cereal Products
Author Method Compound Meal Subjects
Percent
Absorption from
Elemental Iron
Percent
Absorption
from Ferrous
Sulfate or
Common
Pool*
Ho¨glund &
Reizenstein5 5
Radioactive
WBC
Reduced iron.
Coarse:
23% 20–30
m, 48%
30 m
60 g wheat
roll with
1 mg Fe
Adults 8–13/
group,
separate
groups
Course: 3.0 0.8 19.8 5.7
Fine: 97% ca.
5 m
Fine: 9.0 5.7
Cook et al.2 7 Radioactive
WBC
H-reduced
iron,
5–10 m
60 g wheat
roll with
3 mg Fe
Adults,
8/group,
separate
groups
8.6 9.1
Rios et al.19 Radioactive
WBC
H-reduced
iron,
5–10 m
10 g cereal
(wheat, oat,
malt) with
5 mg Fe
plus
formula
Infants (5–7
m) 12/25
group,
separate
groups
4.0 (SEM
3.4–4.9)
2.7 (SEM
2.3–3.2)
Bjo¨rn-Rasmussen
et al.31
WBC plus
erythrocyte
incorporation
H-reduced
iron
60 g wheat
roll with
1 mg Fe
Adults, 6–8/
group,
paired
E11 15.6 6.8 18.5 7.7
E12 19.2 4.7 21.8 5.8
E12 7.0 1.9 10.6 2.8
E14 2.5 0.3 19.9 2.1
Hallberg et al.28 Radioactive
WBC plus
erythrocyte
incorporation
BASF,
carbonyl
iron
40 g bread
(1 mg Fe)
with
margarine,
marmalade,
and coffee
Adults, 8–10/
group,
paired
1.0 5.6
40 g bread
(1 mg Fe)
with
margarine,
and milk
0.5 5.5
40 g bread
(1 mg Fe)
with
hamburger,
potatoes,
and beans
1.7 12.7
40 g bread
(1 mg Fe)
with meat
soup
1.1 20.1
Forbes et al.4 0 Radioactive
erythrocyte
incorporation
Electrolytic,
10–30 m
40 g wheat
farina, 120
mL milk,
and 1 mg
Fe
Adults, 10/
group,
paired
3.37 (SEM
2.62, 4.35)
4.52 (SEM
3.53, 5.78)
Roe &
Fairweather-
Tait5 6
Stable
isotopes,
fecal
monitoring
H-reduced Bread roll
with 1 mg
Fe and
Coca Cola
Adults, 10/
group
64.8 4.2 —
*Absorption of ferrous sulfate added to cereal products in an identical manner to the elemental iron (References 19, 27, 40, 55) or
absorption of pool iron as measured by extrinsic tag (References 28, 31). WBC whole body counter.
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presence of phytic acid, even though the cereal was fed
mixed with an infant formula, which can be assumed to
contain ascorbic acid. The same small particle size iron
powder (5–10 m) or ferrous sulfate, added to a low-
extraction bread roll at a level of 3 mg iron, gave an iron
absorption of approximately 9% in adults.27 Compared
with ferrous sulfate, the RBV of H-reduced iron was 95;
this was much higher than the RBV values of 31 and 5
reported for ferric orthophosphate and sodium iron py-
rophosphate, respectively.
In the three other studies with reduced iron, 1 mg of
iron was added and fed in a bread roll. Two of these
studies were done with radioisotopes and used either a
whole body counter or erythrocyte incorporation of the
radioisotopes to evaluate iron absorption. In the study of
Ho¨glund and Reizenstein,55 30 g white bread was forti-
 ed with 1 mg radio-labeled reduced iron of the  ne (ca.
5 m) or coarse ( 48% of the particles 30 m)
variety. Using a whole body counter, they compared
elemental iron absorption in human volunteers with that
of ferrous sulfate. Mean absorption of the “coarse” ele-
mental iron was 3% and absorption of the “ ne” elemen-
tal iron was 6%, representing an RBV relative to ferrous
sulfate of 15 and 45, respectively. Bjo¨rn-Rasmussen et
al.31 also fed 1 mg of different radio-labeled experimen-
tal reduced iron powders in 60 g wheat rolls, made from
60%-extraction wheat  our, to healthy volunteers and
measured iron absorption by both hemoglobin incorpo-
ration and whole body counting. Absorption depended
on the solubility of the powder in dilute acid, the surface
area of the iron particles, and the particle size. In subjects
with relatively low iron stores, iron absorption was 2.5 to
19%, representing RBV values of 13 to 90% relative to
absorption of native bread iron labeled extrinsically with
59FeCl3.
The third, more recent study was done with stable
isotopes. Iron absorption was measured from the amount
of added iron isotope excreted in the stool in ten non-
anemic adult females with moderately low iron stores
(mean plasma ferritin 24 g/L).56 The reported absorp-
tion was 65%, much higher than any previously reported
values. The reduced iron powder used in this study was
produced experimentally by a stable isotope manufac-
turer and was reported to have a solubility in dilute acid
similar to that of a commercial reduced iron powder.
There was no direct comparison with ferrous sulfate
added to bread. There are two possible explanations for
this unusually high absorption. Firstly, it is possible that
the fecal monitoring technique used generated falsely
high absorption values. This is suggested by the high
mean iron absorption (50%) from a reference dose of 3
mg iron as ferrous sulfate and 30 mg ascorbic acid. A
40% reference dose absorption usually indicates that
subjects have reduced iron stores. Secondly, the bread
rolls were fed with Coca Cola¨ , a beverage of low pH,
which could have facilitated the dissolution of the iron
powder in the gastric juice and thus elevated absorption.
Although the high absorption reported in this study is
inconsistent with previous studies using radioisotopes
and whole body counting, the results suggest that re-
duced iron powders of high relative bioavailability can
be produced. This conclusion is in agreement with the
results from earlier studies,19,27 which reported similar
absorption values from H-reduced iron powders and
ferrous sulfate.
Electrolytic Iron
The electrolytic iron powder tested by Forbes et al.40was
similar but not identical to commercial electrolytic iron
passing through a 325-mesh sieve (Glidden A-131).
Absorption from a 3 mg iron dose by adult volunteers of
normal iron status from a meal of wheat farina and milk
was 3.4%, which represented 75% of the absorption of
ferrous sulfate from the same meal. The addition of 100
mg ascorbic acid to the test meal increased the absorp-
tion of electrolytic iron to 8% without greatly changing
its RBV value.
Carbonyl Iron
After extensive studies on the bioavailability in humans
of carbonyl iron added to bread rolls, Hallberg et al.28
recommended the need to reconsider the rationale for
using elemental iron powders for food forti cation.
These investigators irradiated food-grade carbonyl iron
(BASF) in a nuclear reactor for approximately 10 days at
a temperature of 100°C. The powder was left to stand
for at least 500 days so as to allow for the decay of 59Fe
and other unwanted radioisotopes, after which time the
55Fe-labeled carbonyl iron was added to 60%-extraction
wheat  our and baked into bread rolls. One, two, and
three mg of carbonyl iron were added to each 40 g roll
representing forti cation levels of 2.5, 5.0, and 7.5 mg/
100 g  our. A total of 15 separate iron absorption studies
were carried out in seven to ten human subjects per
study; forti ed rolls were fed with marmalade, marga-
rine, and coffee for breakfast or as part of a composite
meal with either hamburger or vegetable/meat soup.
Mean iron absorption from the breakfast meals was 1.4%
(range 0.5–2.7%), which represented a mean RBV value
of 22 (range 9–33) when compared with the absorption
of native meal iron labeled with 59FeCl3. Mean RBV was
even lower with the hamburger meals and meat/vegeta-
ble soup at 13 and 5, respectively.
These results were somewhat surprising at the time
because the reported RBV values in rats for carbonyl
iron were closer to 50.47 The data on solubility and
particle size, as well as the rat studies, had suggested
carbonyl iron was at least as good as, if not better than,
reduced iron and electrolytic iron.47 The carbonyl iron
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irradiated by Hallberg et al.28 was subsequently reported
to have an RBV value in rats of 35.53 One might be
tempted to suggest that the irradiation and storage of the
commercial carbonyl iron powder may have changed its
properties, but its solubility in dilute HCl at pH 1 and pH
3 was unchanged and similar to that of a commercial
electrolytic iron powder (Glidden A-131). After 30 min-
utes, 85% of all tested compounds dissolved at pH 1 but
only 6% dissolved at pH 3. Hallberg et al.28 suggested
that differences in gastric pH after a meal and different
gastric residence time could be extremely important
factors because the variation in RBV of carbonyl iron
observed with the different meals was probably due to
different rates and extent of solubility of the iron powder
in the gastric juice. Owing in part to the results of this
study, iron forti cation of wheat  our with carbonyl iron
was discontinued in Sweden some 10 years later.
Predicting the Absorption of Elemental Iron
Based on the Measured Absorption of Ferrous
Sulfate
Another way to predict the absorption of elemental iron
powders from a cereal product is to relate it to the
measured absorption of ferrous sulfate. At best, the
absorption of an elemental iron powder would be equiv-
alent to that of ferrous sulfate, but, in most cases, it
would be much less. Rat assays would predict that
electrolytic and carbonyl iron powders are approximately
half as well absorbed as ferrous sulfate and that reduced
iron powders are 20 to 50% as well absorbed as ferrous
sulfate. (Tables 2–4) Studies reporting iron absorption
by human subjects from ferrous sulfate–forti ed bread
and infant cereals are listed in Table 7. Iron absorption
by adults with normal iron status from bread rolls made
from 60%-extraction  our containing 1.7 to 2.5 mg iron
as ferrous sulfate was reported to be 5.7 to 8.6%.60,61
Iron absorption by adults from wheat rolls made from
80%-extraction  our, however, fell to approximately 1%,
presumably owing to the high phytic acid content. Iron
absorption by infants from whole grain infant cereal,
whole meal bread, and a breakfast cereal was similarly
low (3.1–3.8%).57,59 Phytic acid is a potent inhibitor of
iron absorption62,63 but can be partially degraded during
the yeast fermentation step of the bread baking process,
and completely degraded if low-extraction  our and
prolonged fermentation times are used.61,62 Another ef-
fective means of increasing the bioavailability of forti -
cation iron is to add ascorbic acid—a potent enhancer of
iron absorption—to cereal porridges and infant cereals.35
Its effectiveness has been shown in several studies. For
example, iron absorption from a commercial infant ce-
real, based on wheat and cow’s milk and forti ed with
ferrous sulfate and ascorbic acid, was reported to be
8.7% in infants58 and 2.6 to 4.3% in adults.22Without the
addition of ascorbic acid, iron absorption by adults from
a ferrous sulfate–forti ed wheat porridge was 2.2%; this
number fell to 1% when soy protein isolate was
added.61 Iron absorption by infants from whole meal
bread forti ed with ferrous sulfate increased from 3.1%
to 7.5% when the bread was consumed with a drink
containing 50 mg ascorbic acid.57
Extrapolation of Findings to Elemental Iron
There are two concerns when attempting to predict the
absorption of an elemental iron powder from a forti ed
cereal product. The  rst concern is that the elemental
iron powder is less bioavailable than ferrous sulfate
because it does not dissolve as well in the gastric juice.
The second concern relates to the nature of the diet. The
proportion of elemental powder that is available for
absorption is then exposed to inhibitors, such as phytic
acid, so that the amount  nally absorbed may be reduced
to unacceptably low levels. From the published human
bioavailability studies, only Hallberg et al.28 tested a
commercial iron powder and reported absorption values
of 1 to 2% in subjects with normal iron status consuming
composite meals together with the forti ed bread roll.
Forbes et al.40 tested an experimental electrolytic iron
powder of similar particle size to the commercial powder
that was passed through a 325-mesh sieve and reported
an absorption of 3.4% for a meal based on wheat farina
and milk.
Much higher absorption values from experimental
elemental iron powders and ferrous sulfate have been
reported when the iron compound is fed with a simple
bread meal and when low-extraction  our containing
little or no phytic acid is used to make the bread. With 1
mg added iron, absorption values as high as 10 to 20%
have been reported in subjects with normal iron status
(Table 6) for both elemental iron powders and ferrous
sulfate. With 1.7 to 2.5 mg added iron, reported absorp-
tion is in the range of 6 to 9%. (Table 7) In the presence
of phytic acid, however, such as in bread made from
80%-extraction or whole meal  our, iron absorption
from ferrous sulfate may fall to 1% or less. (Table 7)
Human Studies Monitoring Iron Status
Elwood et al.64 tried, in two separate studies, to demon-
strate the bene cial effect of the U.K.  our enrichment
program (16 mg iron/kg) on the iron status of free-living
women. The  rst study was a therapeutic trial monitoring
the in uence of iron-forti ed bread as an integral part of
the normal diet on the hemoglobin concentration of
mildly anemic women. The second study was termed a
prophylactic trial because the anemic women were  rst
treated with iron to increase their hemoglobin concen-
tration; then the ability of the iron-forti ed bread to
maintain the higher hemoglobin levels was monitored. In
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the  rst trial, bread was forti ed with either reduced iron
or ferric ammonium citrate and provided approximately
1 mg extra iron per day, which increases the daily iron
intake by approximately 10%. In the second trial, bread
was forti ed with ferric ammonium citrate at a higher
level (27 mg/kg instead of 16 mg/kg), which provided
2.7 mg extra iron per day. Elwood et al.64 concluded that
neither trial provided conclusive evidence of any bene-
 cial effect of wheat  our forti cation on iron status,
even though the reduced iron–forti ed bread gave a
small but statistically signi cant increase in hemoglobin
(0.24 g/dL) after 9 months of intervention. In another
study, Elwood30 carried out a therapeutic trial that fed
reduced iron–forti ed bread to a group of anemic pa-
tients in a mental hospital. He found no bene cial effect
on hemoglobin after periods of 3 to 6 months, although
a similar amount of iron given as ferrous gluconate
caused a rise in mean hemoglobin in another group of
anemic patients.
There is only one published study reporting im-
proved iron status in a population fed regularly with an
elemental iron–forti ed cereal. This study was done in
Chile by feeding an infant cereal forti ed with Glidden
A131 electrolytic iron.50 Iron status was monitored in
groups of approximately 100 infants from 4 months to 15
months of age. The infants consumed 25–30 g rice infant
cereal per day, either unforti ed, or forti ed with 55 mg
electrolytic iron/100 g, which provided some 14 to 17 mg
Table 7. Iron Absorption in Human Subjects from Ferrous Sulfate–fortied Bread and Infant Cereals
Author Method Meal Subjects % Iron Absorption
Hurrell et al.22 Radioisotopes,
erythrocyte
incorporation
100 g wheat/milk
infant cereal
300 mL water, 7.5 mg
Fe, 35 mg ascorbic
acid
Adults, 10–13 subjects/
study
2.58 (SEM 1.82, 3.66)
4.28 (SEM 3.17, 5.78)
Faiweather-Tait et al.57 Stable isotopes,
erythrocyte
incorporation
Weetabix breakfast, 20
g cereal, 85 g milk,
0.7 mg Fe, 4 mg
ascorbic acid
Infants, 9 months, 10
subjects/group
3.0 (SD 1.1, 8.3)
22 g whole wheat
bread, 6 g
margarine, 0.5 g
marmite, 0.6 mg Fe,
0.3 mg ascorbic acid
3.1 (SD 1.4, 6.7)
Davidsson et al.58 Stable isotopes,
erythrocyte
incorporation
25 g wheat/milk infant
cereal, 100 mL
water, 2.5 mg Fe,
ascorbic acid/Fe 2:1
molar ratio
Infants, 5–9 months,
12 subjects/study
8.7 (range 3.8–10.9)
Fox et al.59 Stable isotopes,
erythrocyte
incorporation
20 g whole grain
weaning cereal
(wheat, rice, oat,
rye, wheat bran), 1.6
mg Fe
Infants, 9 months, 24
subjects/study
3.8 (SEM 2.9, 4.7)
Hurrell et al.60 Radioisotopes,
erythrocyte
incorporation
50 g 60%-extraction
wheat bread roll, 1.7
mg Fe
Adults, 7
subjects/study
8.64 (SEM 6.0, 12.4)
Hurrell et al.61 Radioisotopes,
erythrocyte
incorporation
50 g 60%-extraction
wheat bread roll, 2.5
mg Fe
Adults, 8–10 subjects/
study
5.7 (SEM 4.30, 7.55)
50 g 80%-extraction
wheat bread roll, 2.5
mg Fe
0.99 (SEM 0.72, 1.36)
50 g 60%-extraction
wheat cereal
porridge, 5 mg Fe
2.2 (SEM 1.36, 2.91)
50 g wheat/soy cereal
porridge, 5 mg Fe
0.73 (SEM 0.49, 1.07)
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additional iron per day. The cereals were mixed with a
non-iron–forti ed formula containing 66 mg ascorbic
acid/L. Some infants continued to be breastfed, whereas
others were fed the non-iron–forti ed formula, both in
addition to their normal diet that included fruits and fruit
juices from 3 months, meat, and vegetables from 4
months, and regular table foods from 9 months. At 15
months, 15% of the breastfed infants consuming the
non-iron–forti ed cereal were diagnosedwith IDA, com-
pared with only 3% of those infants consuming the cereal
forti ed with electrolytic iron. In the infants fed the
non-iron–forti ed formula, the corresponding numbers
were 17 and 6%. The authors concluded that cereal
forti ed with electrolytic iron could contribute substan-
tially to preventing IDA. Whereas this is true, it should
be emphasized that IDA was not eradicated completely
in this study even though the cereal provided an extra 14
to 17 mg iron per day. The iron was ingested with a
formula containing ascorbic acid, which facilitates ab-
sorption, and was in addition to the iron provided in the
normal diet. Assuming 5% absorption from the forti -
cation iron, enough iron would be absorbed from the
cereal to provide most of the iron requirement of a 6- to
12-month-old infant, which is estimated to be 0.9 mg/
day.65
Adapting Iron Fortication to Different Dietary
Settings
Ultimately, the usefulness of elemental iron for food
forti cation depends on the ability of the forti ed food,
when consumed as part of the normal diet, to prevent
iron de ciency in at-risk population groups. Iron bio-
availability, which is a key factor in this process, de-
pends on the nature and level of elemental iron added to
the food, the amount of forti ed food consumed, the iron
status of the consumer, and the presence of inhibitors and
enhancers of iron absorption in the cereal vehicle and the
overall diet.
A successful iron forti cation strategy is much more
easily established in industrialized countries than in de-
veloping countries. From a logistic standpoint, the prep-
aration and distribution of forti ed cereals are usually
more ef cient and the mixed diets consumed by such
populations contain fewer inhibitors of iron absorption
and more enhancers, such as meat and ascorbic acid. By
contrast, central distribution is often a problem in devel-
oping countries. In addition, staple cereal diets have high
phytate and low ascorbic contents, whereas other inhib-
itors, such as polyphenols, which are present in tea,
legumes, and sorghum, often pose an added prob-
lem.13,14 As a result, the absorption of all forti cation
compounds would be expected to be low.61 In develop-
ing countries, the problem of iron forti cation is also
complicated by a number of other factors. In addition to
poor bioavailability of iron from cereal-based diets, hel-
minth infections and particularly blood loss from hook-
worm infections66 contribute to the problem of iron
de ciency in many areas. Other important etiologic fac-
tors expected to blunt the effect of forti cation programs
include folate de ciency,67 vitamin A de ciency,68 a
variety of infections including malaria and HIV infec-
tion,69 and hemoglobinopathies.70
As mentioned above, it is possible to enhance iron
absorption from commercial infant cereals forti ed with
elemental iron powders and other iron compounds by the
addition of ascorbic acid35,42 or by phytate degrada-
tion.35,58 It is much more dif cult to do so in developing
countries, however, because ascorbic acid is unstable
when stored in hot and humid climates unless it is
encapsulated or stored in sophisticated packaging.
Whereas nutritional campaigns to encourage the con-
sumption of more fruits and vegetables or muscle tissue
in the diet are highly desirable, such approaches are not
always possible or practical. Sodium EDTA, which is
stable during storage, is another potential enhancer of
forti cation iron absorption. It has been demonstrated to
enhance the absorption of ferrous sulfate from cereal
foods,61 but its in uence on the absorption of elemental
iron powders remains to be established.
Conclusions and Recommendations
The following conclusions are based on the preceding
literature review and discussions, which took place at
and after the SUSTAIN workshop in Monterrey.
Forti cation of milled, re ned cereals is a conve-
nient way to deliver iron and other micronutrients to a
general population whose diets are de cient in those
micronutrients. Iron should be included in cereal forti -
cation or enrichment programs in countries in which IDA
is prevalent.
Because of its high bioavailability and low cost,
FCC-grade dried ferrous sulfate is often the best iron
source when cereals are to be stored for only short
periods. It can be used in bakery  our, semolina, and
other types of low-extraction wheat  ours, which are
normally used within one to two months after produc-
tion. Ferrous sulfate should be a  ne–particle size, dried
material. FCC-grade ferrous fumarate is another good
choice because it has a bioavailability similar to that of
ferrous sulfate. It is insoluble in water and therefore
causes fewer organoleptic problems than the more solu-
ble ferrous sulfate. However, it is typically more costly
than ferrous sulfate.
Elemental iron powders have been used for cereal
forti cation for more than 50 years and continue to be
the most widely used iron compound for this purpose.
They have the advantage of causing few, if any, color
and  avor problems in stored food vehicles. They are
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inexpensive and suitable for forti cation of staple foods
such as wheat  our and maize  our. Absorption of
elemental iron powders is lower than that of other iron
forti cants, such as ferrous sulfate and ferrous fumarate,
and is less predictable.
From the information currently available, there are
three major types of iron powders in use:
Reduced iron (North American Ho¨gana¨s [H-reduced],
Ho¨gana¨s AB [CO-reduced], Quebec Metal Powders
[reduced])
Electrolytic iron (OMG Americas; Industrial Metal
Powders)
Carbonyl iron (BASF, International Speciality Pow-
ders)
FCC guidelines specify that reduced iron powders
must have a particle size of 150 m (100 mesh).
Electrolytic and carbonyl iron powders must have a
particle size of 45 m (325 mesh). Based on current
information, the relative costs of available elemental iron
powders vary by a factor of approximately seven, with
carbonyl iron being the most expensive and 100-mesh
reduced iron the least expensive. Most reduced iron
powders currently used to fortify foods in North America
and Europe have a particle size of 300 or 325 mesh.
Reduced iron of larger particle size (100 mesh), how-
ever, is being used in some developing countries, pre-
sumably because of the lower cost.
Elemental iron powders have been evaluated in
several ways in relation to potential absorption in man.
The methods used include the measurements of physico-
chemical characteristics, solubility in dilute acid, dialys-
ability in vitro, hemoglobin repletion in anemic rats,
bioavailability in human isotopic studies, and human
ef cacy studies. Although useful information has been
obtained from all of these studies, it is important to
emphasize the lack of uniformity in solubility and dia-
lysability experiments. By contrast, hemoglobin reple-
tion studies in rats have provided seemingly valid data on
the commercial elemental iron powders in use at the time
of the studies. The powders tested between 1971 and
1991, however, may have had different characteristics
from those currently available. With one or two excep-
tions, the elemental powders tested in human bioavail-
ability studies were very different from commercially
available products.
Reduced Iron Powders
Results from rat studies on commercial reduced iron
powders done between 1971 and 1991 indicated that
hydrogen-reduced powders were less well absorbed than
electrolytic iron and that carbon monoxide–reduced
powders were very poorly absorbed. Because it is not
known whether the reduced iron powders tested are the
same as those presently being produced, there is no
available evidence to evaluate the usefulness of reduced
iron powders currently used for food forti cation. Until it
can be demonstrated that large particle size reduced iron
powders of 150 m (100 mesh) have a bioavailability
equivalent to 45 m (325 mesh) powder, they cannot
be recommended for food forti cation.
Human bioavailability studies with isotopes have
shown that small particle size powders ( 10 m) are
absorbed as well as ferrous sulfate. However, the tech-
nical feasibility and cost of producing such powders have
not been evaluated. Whereas particle size has been a
major criterion in assessing reduced iron powders, it is
possible that novel production techniques may lead to
soluble particles of larger size in the future.
Electrolytic Iron
The information currently available suggests that elec-
trolytic iron ( 45 m, 325 mesh, with a dendritic struc-
ture similar to Glidden A131) should be a useful iron
forti cant. This is based on the following evidence: an
improvement in iron status of infants consuming an
electrolytic iron–forti ed infant cereal; a human bio-
availability study with radio-labeled electrolytic iron
having similar but not identical characteristics to the
commercial products resulting in an absorption 75% of
that of ferrous sulfate; and rat hemoglobin repletion
studies with electrolytic iron powders similar to those
being marketed today showing a relative bioavailability
approximately 50% of that of ferrous sulfate.
Carbonyl Iron
Carbonyl iron has limited value in food forti cation
because of its high cost. There is also con icting evi-
dence concerning its bioavailability. Rat hemoglobin
repletion studies with carbonyl iron powders have shown
relative bioavailability of approximately 50% of that of
ferrous sulfate; whereas it has been used therapeutically
in very large doses ( 1.5 g/day), however, the absorp-
tion has been found to be very low (0.5–2.0%). Finally,
extensive bioavailability studies with irradiated carbonyl
iron in a variety of meals have demonstrated a low RBV
of 5% to 33%.
Fortication Efcacy
Iron forti cation of cereals has been used widely as a
public health intervention strategy. In industrialized
countries with high bioavailabilitydiets, this strategy has
been assumed to have a bene cial effect on iron status. In
populations consuming low bioavailability diets, such as
those consumed in many developing countries, the po-
tential bene t may be much less, and much greater
amounts of forti cation iron may have to be added.
Because the impact of fortifying low bioavailabilitydiets
may be limited and because changes in iron status take
place slowly, forti cation should be considered as only
one of several strategies. Other strategies could include
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improving the overall quality of the diet by including
promoters of iron absorption (e.g., ascorbic acid in citrus
fruits, ripe papaya, and guavas, etc.); adding a facilitator
of iron absorption, such as EDTA or ascorbic acid, to the
forti ed food vehicle; reducing the content of inhibitors
consumed with meals (e.g., tea, coffee, or cocoa prod-
ucts); and adding the forti cation iron to a food vehicle
consumed separately from the main inhibitory meals.
The Way Ahead
Not enough is known about the characteristics and rela-
tive bioavailability of the commercial elemental iron
powders that are currently available. Because only a few
powders are used, it is suggested that these powders can
be screened using a variety of established methods.
Initially, these tests should all be conducted on the same
batch of iron powder to establish comparability between
laboratories and should include physicochemical charac-
teristics, solubility in dilute acid, in vitro dialysability,
CaCo-2 cell uptake, and hemoglobin repletion test in
rats. At the same time, human bioavailability can be
evaluated by serum iron curves, isotopic measurements
of absorption (the labeled powders used in such studies
must be prepared with characteristics as close as possible
to the commercial powders), and by measuring the effect
on iron status of human populations in  eld ef cacy
trials.
The current speci cations for elemental iron pow-
ders are based on particle size, but there is evidence that
other factors may be as important, or more important, in
predicting bioavailability. By correlating the results of
bioavailability studies with in-vitro tests, it should be
possible to develop standardized techniques for predict-
ing bioavailability. The development of a standardized
test, based on solubility within a speci c pH range,
appears to be an attractive option. Once we have better
characterized the iron powders available today, and de-
veloped simple, reliable quality control methodologies, it
should be possible to manufacture and select suitable
elemental iron powders for food forti cation.
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Erratum
In the November 2002 issue of Nutrition Reviews, the issue number was erroneously printed as No. 12. The correct
issue number is No. 11.
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